Assay bias may invalidate decision limits and affect comparability of serum thyroglobulin assay methods: an approach to reduce interpretation differences
HA Ross, RT Netea-Maier, E Schakenraad… - Clinica Chimica …, 2008 - Elsevier
BACKGROUND: Thyroglobulin (Tg) assays are used to monitor patients after ablative
therapy for differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or …
therapy for differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or …
Assay bias may invalidate decision limits and affect comparability of serum thyroglobulin assay methods: an approach to reduce interpretation differences
HA Ross, RT Netea-Maier… - … journal of clinical …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Thyroglobulin (Tg) assays are used to monitor patients after ablative therapy for
differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or recurrence of …
differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or recurrence of …
[引用][C] Assay bias may invalidate decision limits and affect comparability of serum thyroglobulin assay methods: an approach to reduce interpretation differences.
HA Ross, RT Netea-Maier, EL Schakenraad… - 2008 - repository.ubn.ru.nl
BACKGROUND: Thyroglobulin (Tg) assays are used to monitor patients after ablative
therapy for differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or …
therapy for differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or …
Assay bias may invalidate decision limits and affect comparability of serum thyroglobulin assay methods: An approach to reduce interpretation differences
A Ross, R Netea-Maier, E Schakenraad… - Clinica Chimica …, 2008 - researchportal.vub.be
Background: Thyroglobulin (Tg) assays are used to monitor patients after ablative therapy
for differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or recurrence …
for differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or recurrence …
Assay bias may invalidate decision limits and affect comparability of serum thyroglobulin assay methods: An approach to reduce interpretation differences
HA Ross, RT Netea-Maier, E Schakenraad… - Clinica Chimica …, 2008 - infona.pl
Thyroglobulin (Tg) assays are used to monitor patients after ablative therapy for
differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or recurrence of …
differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or recurrence of …
Assay bias may invalidate decision limits and affect comparability of serum thyroglobulin assay methods: an approach to reduce interpretation differences.
HA Ross, RT Netea-Maier, E Schakenraad… - Clinica Chimica Acta; …, 2008 - europepmc.org
Background Thyroglobulin (Tg) assays are used to monitor patients after ablative therapy for
differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or recurrence of …
differentiated thyroid carcinoma (DTC). Detectable Tg suggests persistence or recurrence of …